# Masafumi Taniwaki

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/masafumi-taniwaki/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,605 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 65 |
| i10-index | 307 |
| Last Known Institution | Kyoto Prefectural University |
| OpenAlex ID | https://openalex.org/A5113628512 |
| Works | 740 |

## Researcher papers

- [Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma](https://scholariq.org/papers/multicenter-phase-ii-study-of-mogamulizumab-kw-0761-a-defucosylated-anti-cc/)
- [Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial](https://scholariq.org/papers/pembrolizumab-plus-pomalidomide-and-dexamethasone-for-patients-with-relapsed-or/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

## Researcher university

- [Kyoto Prefectural University](https://scholariq.org/institutions/kyoto-prefectural-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.